Skip to main content
Premium Trial:

Request an Annual Quote

Perkin-Elmer Proposes to Distribute Celera Stock

Premium

NORWALK, Conn.--Perkin-Elmer announced that, subject to shareholder and final board approval, it plans to distribute a new class of common stock intended to track the separate performance of Celera Genomics, a new business unit formed through an alliance between Perkin-Elmer and Craig Venter, former president of the Institute for Genomic Research, with a mission to become the definitive source for genomic and related biomedical information.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.